𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Decreased purinergic inhibition of synaptic activity in a mouse model of Niemann-Pick disease type C

✍ Scribed by Su-ya Zhou; Shu-jun Xu; Ying-gang Yan; Hui-mei Yu; Shu-cai Ling; Jian-hong Luo

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
715 KB
Volume
21
Category
Article
ISSN
1050-9631

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Niemann‐Pick disease type C (NPC) is a progressive neurodegenerative disorder characterized by accumulation of free cholesterol in lysosomes, mainly due to a mutation in the NPC1 gene. The pathophysiological basis of the neural disorders in NPC, however, is not well understood. We found that the hippocampal field excitatory postsynaptic potential (fEPSP) was enhanced in NPC1 mutant mice. A1‐receptor antagonist or adenosine degrading enzyme enhanced the fEPSP in both types of mice, but had a much weaker effect in the mutant mice, suggesting less tonic inhibition of synaptic transmission by endogenous adenosine in the mutant. Further evidence showed impaired hippocampal long term potentiation (LTP) in mutant mice. Supplement of A1 agonist N6‐Cyclopentyladenosine (CPA) partially rescued the impaired LTP in mutant mice. Moreover, adenosine release from hippocampal slices was significantly decreased in the mutant. The enhanced excitatory synaptic transmission and the decreased synaptic plasticity due to the decreased adenosine release in NPC brain may partially contribute to the neural disorders of NPC disease, such as seizures, neurodegeneration, and dementia. © 2010 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Decreased estradiol release from astrocy
Decreased estradiol release from astrocytes contributes to the neurodegeneration in a mouse model of Niemann-Pick disease type C
✍ Gang Chen; Hai-Min Li; Yi-Ren Chen; Xiao-Song Gu; Shumin Duan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

## Abstract Niemann‐Pick disease type C (NPC) is a deadly neurodegenerative disease often caused by mutation in a gene called NPC1, which results in the accumulation of unesterified cholesterol and glycosphingolipids in the endosomal–lysosomal system. Most studies on the mechanisms of neurodegenera

Selective neurodegeneration, without neu
Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease
✍ Dwight C. German; E. Matthew Quintero; Chang-Lin Liang; Benton Ng; Surender Puni 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 971 KB

## Abstract The BALB/c mouse model of Niemann‐Pick type C (NPC) disease exhibits neuropathological similarities to the human condition. There is an age‐related cerebral atrophy, demyelination of the corpus callosum, and degeneration of cerebellar Purkinje cells in the NPC mouse. In human NPC, many

Amelioration of enteric neuropathology i
Amelioration of enteric neuropathology in a mouse model of Niemann-Pick C by Npc1 expression in enteric glia
✍ Raj Kapur; Carolyn Donohue; David Jelinek; Robert P. Erickson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 590 KB

## Abstract Niemann‐Pick C (NPC) disease is an autosomal recessive, lethal, neurodegenerative disorder caused by mutations in __NPC1__. By using the glial fibrillary acidic protein (GFAP) promoter, we demonstrated previously that astrocyte‐specific expression of __Npc1__ decreased neuronal storage

A point mutation in the lariat branch po
A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease
✍ Enza Di Leo; Francesca Panico; Patrizia Tarugi; Carla Battisti; Antonio Federico 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 1 views

The lariat branch point sequence (BPS) is crucial for splicing pre-mRNA even if BPS mutations have infrequently been reported in human disease. In two siblings with Niemann-Pick type C (NPC) disease we identified two mutations of the NPC1 gene: i) one in exon 20 (c.2932C>T) (p.R978C) previously repo